Contract analysis

I. Executive Summary This memorandum summarizes the material terms, conditions, exclusions, and practical implications of the buy-side representations and warranties insurance ("RWI") policy obtained in connection with Solstice Biomedical, Inc.'s acquisition of one hundred percent (100%) of the outstanding common stock and all vested options of Meridian Surgical Technologies, Inc. (the "Transaction"). The Transaction

II. Policy Parties and Structure A. Named Insured The Named Insured under the RWI policy is Solstice Biomedical, Inc., a Delaware corporation that serves as the acquisition subsidiary and the U.S. borrower in connection with the Transaction. Solstice Biomedical, Inc. is located at 1200 Innovation Drive, Suite 400, Wilmington, DE 19801. As the Named Insured, Solstice Biomedical, Inc. has the primary right to submit cl

III. Coverage Terms A. Aggregate Coverage Limit The aggregate limit of liability under the RWI policy is Forty Million Dollars ($40,000,000). This limit represents the maximum total amount payable by Ridgeline under the policy across all covered claims during the policy period, regardless of the number of individual claims made or the nature of the breached representations. Relative to the Transaction economics, the

IV. Key Exclusions The RWI policy contains a number of exclusions from coverage, some of which are deal-specific and some of which are standard market exclusions. An understanding of these exclusions is critical to assessing the scope and limitations of the coverage provided by the policy. The following is a summary of the most significant exclusions. A. Known Breaches / Deal-Specific Exclusions Disclosure Schedule E

V. Interplay with the SPA Indemnification Framework One of the most important aspects of the RWI policy is its interaction with the indemnification provisions of the SPA. The RWI policy was procured as an integral component of the Transaction's overall risk allocation framework, and the two mechanisms — contractual indemnification and insurance — are designed to work in concert to provide Solstice with layered protec

VI. Claims Process A. Notice Requirements Timely and proper notice is essential to preserving coverage under the RWI policy. The policy's notice requirements are as follows: Timing: The Insured must provide written notice to Ridgeline as soon as practicable, but in no event later than thirty (30) days after the Insured becomes aware of a circumstance, event, or set of facts that could reasonably be expected to give r

VII. Subrogation A. No Subrogation Against Sellers (General Rule) The RWI policy includes a waiver of subrogation against the Sellers and the Sellers' Representative, Dr. Marcus Ellsworth. This means that if Ridgeline pays a claim to Solstice under the policy, Ridgeline will not seek reimbursement from the Sellers for the amounts paid, and will not "step into the shoes" of Solstice to pursue indemnification claims ag

VIII. Practical Considerations and Recommendations A. Premium Payment and Cost Allocation The $1,232,000 premium for the RWI policy is borne entirely by the Buyer as a Closing cost. The premium payment should be included in the Funds Flow Memorandum for the Closing and will be wired to Ridgeline on October 31, 2024, concurrently with the other Closing payments. Calderwood & Harkness LLP will coordinate with the Buyer